— Second U.S. site to deploy the Reveos^™ system, boosting platelet supply and reducing waste

LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ — To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to implement the Reveos^™ Automated Blood Processing System and the Lumia^™ Software Platform from Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company and global leader in blood management solutions. The move marks a significant step forward in transforming how blood centers process blood in the U.S.

Already used globally in more than 60 countries, Reveos brings a decade of proven performance to the U.S. market. Cleared by the U.S. Food and Drug Administration (FDA) in August 2023, Reveos is the only whole blood automation system available in the U.S. that separates whole blood into platelets, plasma and red blood cells in a single fully automated centrifugation cycle.

This technology enables faster processing, greater efficiency in blood component production compared to manual methods and consistently high product quality — helping blood centers meet growing demand for platelets while improving operational performance.

Why whole blood automation matters

Across the United States, blood centers are facing mounting challenges: platelet shortages, staffing constraints and aging donor populations are straining the system.^[1,2] Nearly 98% of the U.S. platelet supply comes from apheresis donations — a process through which platelets are collected directly from a single donor using specialized equipment over a longer session.^[3] Until now, apheresis has been the primary collection method to produce platelets in the U.S.

Whole blood-derived platelets (WBDPs) offer a complementary solution. Instead of collecting platelets directly, blood centers collect whole blood and then separate it into its components, including platelets, after donation. Historically, this was done using manual methods that took up to 26 steps and were less efficient and more variable. Automation through Reveos has changed that. Now, WBDPs can be produced consistently and quickly, helping organizations like The Blood Center — which must collect 200 to 250 pints of blood daily to meet regional demand^[4] — expand their platelet supply.

“The Blood Center’s adoption of Reveos marks a pivotal moment in the evolution of blood processing in the U.S.,” said Chetan Makam, Senior Vice President and General Manager of Global Blood Solutions at Terumo BCT. “Their commitment to innovation and community impact reflects the very purpose of Reveos, which is to empower blood centers with automation that enhances efficiency, consistency, and responsiveness. We’re proud to support their journey and excited to see the ripple effects this transformation will have across the region.”

A decade in the making

With four devices now in routine use, The Blood Center is realizing its vision of modernized blood processing. The investment helps optimize operational efficiencies, frees up time for staff to do other tasks and enhances the process for platelet production and consistency — helping to benefit donors, hospitals and the broader community.

“This is a milestone moment for our center,” said Mickie Wilson-Martin, Production and Distribution Manager at The Blood Center. “We’ve waited a long time for a solution like this — one that truly modernizes how we manage whole blood. Being among the first in the U.S. to implement Reveos is something we’re incredibly proud of, and it sends a powerful message as we work to attract younger talent. We may be small, but we are mighty, and we’re here for our community.”

From manual to automated: A new era begins

Reveos automates the balancing, centrifuging, expressing, sealing, and data transfer processes — providing efficient blood component production. The Blood Center now produces two types of platelets: apheresis and whole blood-derived, increasing overall availability and flexibility.

“What surprised us most was how quickly our team saw the value — not just in time saved, but in how much more confident we feel about the consistency of every unit,” said Wilson-Martin. “This is mission-critical, as the more efficient we are, the more lives we can save. We can get more blood and more consistent platelets to the hospitals and patients in our communities who depend on us.”

Gary Higgins, Vice President of Administrative Services at The Blood Center, emphasized the importance of consistency from a legal and operational standpoint. A former litigation lawyer, he attributes the consistently high product quality to greater peace of mind.

“Coming from a background in litigation, I’m trained to ask: ‘What’s the worst that can happen, and how do we prevent it?'” said Higgins. “Before Reveos, ensuring every unit met regulatory standards required more manual oversight and effort. Now, we have greater peace of mind. It’s reassuring to know that we’re delivering a product that meets all federal and state requirements, every time.”

Early wins and operational impact

Since implementing Reveos, The Blood Center has already seen measurable improvements, including increased platelet inventory — with up to 100 pooled platelet products manufactured per month — increasing availability for the more than 50 hospitals they serve.*

Other areas seeing improvement:

• Reduced hands-on time, allowing staff to focus on other critical tasks and projects
• Improved product consistency, resulting in a more reliable platelet supply with equivalent therapeutic doses
• Reduced platelet waste due to lower expiration rates with a seven-day platelet shelf life

“It’s not just faster — it’s more predictable,” noted Wilson-Martin. “You gain control over your workflow, which is critical in a field where every drop counts.”

Impact beyond the lab

The benefits of Reveos extend beyond The Blood Center to hospitals and patients across Louisiana. Faster, more efficient processing means a more agile response to routine and emergency needs.

“With Reveos, we’re better prepared to meet the needs of our healthcare partners,” said Wilson-Martin. “We can breathe a little easier now, since we’re no longer worrying about what tomorrow will look like or whether we’ll have the platelets we need. It’s a meaningful step forward in strengthening the blood supply infrastructure for our communities.”

Looking ahead

This announcement is part of a broader movement toward whole blood automation in the U.S. Terumo BCT and The Blood Center will share insights from this transition in a joint abstract at the 2025 Association for the Advancement of Blood and Biotherapies (AABB) Annual Meeting in San Diego, where Billy Weales, President and CEO of The Blood Center, will speak at Terumo BCT’s Science and Innovation Theater session on Monday, October 27, between 11:45 a.m. and 12:45 p.m. PT.

*Data provided by The Blood Center.

About the Reveos™ Automated Blood Processing System

Whole blood units are collected from donors and have traditionally been separated into components — platelets, plasma and red blood cells — using manual methods that took up to 26 steps. Reveos simplifies this process and eliminates over half of the steps. The system aims to help blood centers manage staffing and improve overall efficiency by obtaining more blood products from the same number of donors. It has been used around the world for more than a decade. Reveos is expected to help U.S. blood centers meet the growing demand for platelets, which control bleeding and are used to treat patients facing trauma, cancer and other chronic conditions.

Up to four units of whole blood are loaded into Reveos. The rotor spins, and the whole blood is separated into components. Plasma, platelets and red blood cells are expressed into their respective product bags, and each bag is sealed. After the procedure, the data is recorded using Terumo BCT’s Lumia Software Platform, which connects with Reveos to help blood centers and processing labs achieve operational targets.

Availability varies by region and country. Reveos^™ is either a registered trademark or a trademark of Terumo BCT, Inc. in the United States and/or other countries. See TerumoBCT.com/Trademarks for details.

About The Blood Center

Founded in 1960, The Blood Center is the primary supplier of blood, blood components, and plasma derivatives to local hospitals throughout South Louisiana and parts of the Mississippi Gulf Coast. The Blood Center is a non-profit, community service organization guided by a volunteer Board of Directors, comprised of community leaders and hospital representatives.

The Blood Center’s mission is to provide a quality supply of blood components to meet the needs of the communities it serves, and to provide the technical support needed by the blood banking profession to achieve the highest safety and ethical standards.

The Blood Center supplies over 50 hospitals and numerous outpatient transfusion facilities in Southeast Louisiana and Southern Mississippi. Many of these hospitals, including Children’s Hospital in New Orleans, University Medical Center (Level I Trauma Center) and St. Tammany Parish Hospital, treat patients from throughout this region. 

About Terumo BCT

Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees worldwide believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers.

Terumo Blood and Cell Technologies’ customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 160 countries across the globe. We have 750+ granted patents, with more than 150 additionally pending.

We have global headquarters in Lakewood, Colorado, U.S.A., along with five regional headquarters, eight manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology.

In the news release, 2025 Chery International User Summit: Shaping the Industry’s Future Through Co-Creation and Innovation, issued 21-Oct-2025 by Chery International over PR Newswire, we are advised by the company that the release contained inaccuracies in the description of the “Chery Global ESG Advisory Alliance”. The complete, corrected release follows:

2025 Chery International User Summit: Shaping the Industry’s Future Through Co-Creation and Innovation

WUHU, China, Oct. 21, 2025 /PRNewswire/ — On October 21, 2025, the 2025 Chery International User summit — a global gathering transcending geography and culture — was grandly held in Wuhu, China.

With the theme “Co-Create, Co-Define,” the event brought together more than 3,000 participants from nearly 100 countries, including overseas users, dealership partners, members of the ESG Advisory Alliance, and international media representatives, to engage in an in-depth dialogue about the future of mobility.

In his keynote address at the opening ceremony, Yin Tongyue, Chairman of Chery Automobile Co., Ltd. (9973.HK), elaborated on the strategic essence of “Co-Create, Co-Define.”

From January to September 2025, Chery Group’s global sales surpassed 2 million units, with European sales more than doubling year-on-year to reach 145,000 units, showcasing the tangible value of global co-creation.

Mr. Yin emphasized that Chery is evolving from an automobile manufacturer into a builder of intelligent mobility ecosystems. Guided by the principle “In somewhere, For somewhere, Be somewhere,” the Group continues to advance localization by partnering with local universities and enterprises to develop localized products and nurture local talent, striving to become a truly local enterprise.

He also emphasized that ESG is central to sustainable development. Chery will continue working with international organizations to advance low-carbon technologies and public welfare initiatives, fulfilling its responsibility as a global corporate citizen. Mr. Yin concluded by reaffirming Chery Group’s commitment to building an open, inclusive, and sustainable automotive ecosystem together with its global partners.

Co-Creation — Building an Open and Collaborative User Ecosystem

Global Voices, Shared Stories

At the User Awards Ceremony, representatives from Vietnam, South Africa, Kazakhstan, Spain, and Indonesia shared their stories of connection with Chery.

Le Nguyen Bao Ngoc, brand ambassador for OMODA & JAECOO Vietnam, integrates sustainability into brand communication. Samurai Farai, a South African artist, infused local culture into Chery through creative vehicle art. Mussa Ramazanov from Kazakhstan demonstrated the reliability of EXEED vehicles after driving over 100,000 km. Carlos Guisado from Spain and his family showcased their deep trust by choosing the OMODA & JAECOO brand. Humam from Indonesia built a local community of over 300 Chery owners, forming a thriving content ecosystem.

From CHERY, OMODA & JAECOO, and EXEED to iCAUR, LEPAS, and LUXEED, users around the world are not just customers — they are co-creators shaping Chery’s global brand narrative. Their authentic engagement gives Chery a warmer, more human presence in the global marketplace.

Expanding the ESG Alliance: Building a Global Network for Sustainability

A key highlight of the conference was the launch of the Chery Global ESG Advisory Alliance, marking a major upgrade in Chery’s sustainability strategy.

This year, the alliance expanded significantly — welcoming experts from global sustainability organizations and industrial chain partners.

Notably, former UN Secretary-General Ban Ki-moon attended in person and officially joined the alliance as an ESG Honorary Advisor.

His participation not only enhanced the alliance’s international credibility but also reflected global recognition of Chery’s sustainability roadmap. Through this upgraded alliance, Chery is transforming ESG from an internal corporate initiative into a global collaborative movement, promoting deep cooperation in low-carbon R&D, public welfare programs, and industry standardization.

At the ESG strategy level, Chery has built a comprehensive framework supported by three key pillars: “Low-Carbon Transition and Nature Positive,” “Value Chain Collaboration,” and “Self-Discipline and Compliance Development.” The Group has already made substantial progress across multiple dimensions.

On the technological front, Chery promotes low-carbon transformation through innovations such as the Mars Architecture Hybrid Platform and solid-state battery technology.

On the environmental front, it became the first Chinese automaker to receive a mutual recognition report for Life Cycle Assessment (LCA) between China and the EU.

On the social responsibility front, Chery continues to collaborate with UNICEF on the “Empowering Every Child’s Learning Journey” initiative and works with the IUCN to advance global nature conservation projects — demonstrating its firm commitment to turning ESG promises into tangible action.

Co-Define — Shaping the Strategic Blueprint for Intelligent Mobility

Strategic Elevation Defines a New Paradigm for Intelligent Mobility 

In the grand finale, Mr. Zhang Guibing, President of Chery International, delivered a keynote speech themed “Co-Creating Sustainable Development, Co-Defining the Future Ecosystem,” elaborating on Chery’s strategic evolution from a traditional automaker to a builder of intelligent mobility ecosystems.

He noted that Chery has ranked No.1 among Chinese brands in overseas sales for 22 consecutive years, with monthly exports exceeding 100,000 units for five consecutive months. Its new energy vehicle growth rate leads among China’s top five auto brands, and PHEV models have achieved No.1 retail sales in multiple markets — achievements that firmly validate the foundation of Chery’s strategic transformation.

Driven by the global trends of low-carbon transition and AI intelligence, the automotive industry is rapidly evolving toward an integrated “vehicle + ecosystem” model. In this context, Chery is building a comprehensive technology ecosystem that transcends the traditional automotive domain — one that deeply integrates users, vehicles, robots, and big data.

This system is anchored in intelligent, connected new energy vehicles, while extending into emerging fields such as flying cars, robotaxis, robotics, photovoltaics, and green energy, forming a diversified and synergistic innovation network. Moving forward, Chery will dedicate part of its teams to the automotive business and others to the research, development, and operation of new ventures like robotics, jointly shaping a future-oriented mobility ecosystem.

Mr. Zhang further detailed Chery’s roadmap: Strengthening leadership in PHEV hybrid and BEV electric platforms. Accelerating commercialization of autonomous driving technologies. Advancing innovation in robotics and aerial mobility. Deepening localization under the philosophy “In somewhere, For somewhere, Be somewhere.”

This strategic transformation marks Chery’s evolution from a traditional automaker into a green, intelligent mobility technology company that co-creates, co-defines, and co-prospers with its users and partners. By building an open and collaborative innovation ecosystem, Chery is not only redefining the boundaries of the mobility industry but also opening new pathways for shared growth with global partners.

Co-Create. Co-Define. Co-Win the Future.

Through its dynamic structure of speeches, dialogues, and collaborative announcements, the 2025 Chery International User Summit vividly embodied its theme of “Co-Create, Co-Define.”

From Ban Ki-moon’s participation to user stories from across the globe, from the robotic performances that opened the event to the upgraded ESG Alliance, Chery conveyed a clear message to the world:
It is not building a closed product system, but an open, evolving, user-driven mobility ecosystem.

As technology converges with humanity, and users evolve from product consumers to ecosystem co-creators, Chery’s vision extends beyond cars — toward a new way for people to connect with the world.

SHENZHEN, China, Oct. 22, 2025 /PRNewswire/ — Kismile, a home appliance brand known for its thoughtful design and advanced technology, today announced the launch of its new Drip Coffee Maker, delivering café-level flavor at home with remarkable precision and simplicity.

Built to meet the rigorous SCA and ECBC Gold Cup standards currently under certification, this model ensures every cup achieves the ideal balance of extraction, temperature, and aroma. With both hot and cold brew functions, a touch control interface, and a removable water tank, the Kismile Drip Coffee Maker caters to coffee lovers who value both performance and convenience.

Professional-Grade Thick Film Heating System

At the heart of the Kismile Precision Drip Coffee Maker lies an advanced thick film heating element. This technology enables water to reach the ideal extraction temperature of 197℉-205℉ in just three seconds. This rapid, precise heating is crucial for achieving the perfect “bloom” and full flavor extraction, directly meeting the strict water temperature standards set by both SCA and ECBC.

Engineered for Everyday Perfection

From the first drop to the final sip, every detail is crafted for consistency and comfort. The aluminum alloy body adds modern elegance and durability, while the heating system maintains precise water temperature for optimal extraction.

A magnetic anti-drip design automatically stops flow when the carafe is removed—preventing spills and stains on the warming plate. The detachable water tank makes cleaning effortless and ensures each brew starts with fresh water—solving one of the most common frustrations of traditional coffee machines.

Designed with Real Users in Mind

“Many coffee makers on the market focus on complexity rather than daily use. We wanted to bring the joy of barista-quality coffee into a simple, intuitive design,” said Cyrus Guo, Product Director at Kismile.

“This coffee maker was built to address everyday frustrations—making it easier to clean, more stable in performance, and more enjoyable to use.”

Smart Functionality and Flexible Brewing

The Kismile Drip Coffee Maker offers adjustable coffee flow and strength, allowing users to fine-tune flavor intensity according to their preference. The brewing system is compatible with V-shaped filters, flat-bottom filters, or reusable mesh filters, providing versatility for different coffee styles.

Its Cold Brew Mode extracts smoothly at lower temperatures, delivering a refreshing flavor for warmer days—an exclusive feature rarely found in drip coffee makers. Meanwhile, the heat preservation system keeps coffee between 176℉-185℉ for up to 40 minutes, ensuring every cup stays warm and aromatic.

For easy cleanup, both the brew funnel and glass carafe are dishwasher-safe, combining premium craftsmanship with practical everyday care.

The Kismile Precision Drip Coffee Maker is now available at https://kismile.com/ and on Amazon.

Performance data regarding 3-second heating to optimal extraction temperature (197℉-205℉), temperature precision, and safety features are based on internal laboratory testing under specific conditions. Actual results may vary depending on initial water temperature, ambient temperature, water quality, and altitude. All trademarks mentioned are the property of their respective owners.

About Kismile

Founded in 2015, Kismile is a premium home appliance brand dedicated to combining safety, innovation, and elegant design. From kitchen essentials to smart-featured appliances, Kismile products are built to make modern life simpler, warmer, and more joyful.

Guided by the belief that ordinary life deserves extraordinary care, Kismile continues to innovate appliances that blend style, functionality, and love—empowering every household to savor the beauty of daily living.

BERLIN, Oct. 22, 2025 /PRNewswire/ — Midea’s PortaSplit has been named as one of TIME’s “Best Inventions of 2025” — celebrating products that are changing the world. This marks the first time Midea has received this prestigious honor.

PortaSplit is redefining the residential air conditioning experience with its tool free installation, offering comfort that is both simple and accessible, perfectly compatible with most European window types.

Being able to enjoy the cooling performance of a split air conditioner, but not having to rely on a professional installer, was a welcome innovation for many end users, as they could either not afford a split air conditioning system or were not permitted to do so. Many Europeans sought relief during the increasingly hot summers with portable air conditioners, but by comparison, PortaSplit is more powerful, more efficient and quieter, solving previous pain points in this category.

PortaSplit is also a very efficient air-to-air heat pump, meaning that end users are utilising Midea’s new product, as a very cost-efficient alternative for their primary heating instead of fossil fuels or electrical heating devices. This additional feature is why PortaSplit is referred to as the first DIY-heat pump in the market.

After a very successful launch in Germany, selling out for two summers in a row, PortaSplit was introduced into other European markets including France, Italy, Hungary, as well as Northern Europe and the Baltic states. Rollout will continue across Europe, bringing this solution to more households and further extending its market presence.

PortaSplit is the result of in-depth local research, including home visits and surveys, leading to rapid iterative prototyping. Combining German engineering from Midea’s Stuttgart based R&D Center with Italian design from the Milan Design Center, PortaSplit is a prime example for Midea’s “local for local” strategy.

Being named as one of the “Best Inventions of 2025” proves that Midea is on the right track with its strong focus on local research and development, with many more innovations from Europe in the pipeline.

The CathWorks FFRangio^® System to be Center Stage, Featured in Multiple Scientific Sessions, Live Cases and a Primetime Academic Satellite Program

NEWPORT BEACH, Calif., Oct. 22, 2025 /PRNewswire/ — CathWorks, a global leader in digital health innovations, announced today the schedule of key events for the company during the upcoming Cardiovascular Research Foundation’s annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place October 25 to 28 at the Moscone Center in San Francisco, California.

CathWorks Announces Key Events for TCT 2025.

The CathWorks FFRangio^® System will be featured in multiple abstracts and scientific presentations, live cases and an academic satellite program with an all-star faculty. The CathWorks booth will feature hands-on demonstrations with the latest FFRangio technology and peer-to-peer best practice sharing during Expert Exchange sessions hosted by leading physicians.

Scientific Presentations

• On Monday morning, Dr. Kazuhiro Dan from Ichinomiyanishi Hospital in Japan will present the Initial Report of FFRangio Sizing Tool Guided Percutaneous Coronary Intervention: Insights from FFRangio Sizing Tool and Intravascular Ultrasound Imaging Comparison Study of Japan FFRangio Clinical Outcome Registry.
• On Monday afternoon, Dr. Pedro Carvalho from Minneapolis Heart Institute Foundation in Minnesota will have two presentations featuring the FFRangio System. He will present the Clinical Implementation of Angiography-Derived Fractional Flow Reserve for Revascularization Guidance: A Multicenter Experience in the United States, followed by the Comparison of Predicted Post-PCI Fractional Flow Reserve Derived from CT-based Virtual PCI Versus Observed Angiographic FFR.

Live Cases

• On Monday afternoon, Dr. William Fearon, Dr. Brian Kim and their team at Stanford Health Care in Stanford, California, will perform a live case during the Intravascular Imaging and Physiology session.
• On Tuesday afternoon, Dr. Margaret McEntergart, Dr. Jaikirshan Khatri and their team at Columbia University Irving Medical Center in New York, New York, will perform a live case during the Intravascular Imaging and Physiology session.

Academic Satellite Program

• The Sunday lunchtime satellite program entitled CathWorks FFRangio: Proven Outcomes without Compromise or Complications, will be chaired by Dr. Martin Leon from Columbia University Irving Medical Center, New York, New York. The all-star faculty will include the ALL-RISE^®1 study leadership, including Dr. William Fearon (Stanford University Medical Center, Stanford, California), Dr. Allen Jeremias (St. Francis Hospital, Roslyn, New York), Dr. Ajay Kirtane (Columbia University Irving Medical Center, New York, New York) as well as Dr. Ankitkumar Patel (Hackensack Meridian Mountainside Medical Center, Montclair, New Jersey). The expert physician panel will share the latest body of clinical evidence, the advantages of the FFRangio System compared to other angio-based physiology technologies and how the FFRangio technology is helping physicians make more informed treatment decisions for their patients with CAD.

“We are extremely pleased that once again, CathWorks will have a prominent presence throughout TCT, underscoring the new era in physiology and shift in the interventional cardiology community towards non-invasive solutions that can not only inform treatment decisions but also guide optimal PCI. We look forward to continuing to work closely with our physician partners to make FFRangio the standard of care across the globe, redefining coronary physiology and its potential,” said Ramin Mousavi, President and CEO of CathWorks.

To learn more about CathWorks’ events at TCT 2025, visit TCT 2025 – CathWorks or the CathWorks booth #1461 during the conference.

ABOUT CATHWORKS

CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio^® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFRangio values for the entire coronary tree. For more information on CathWorks, visit www.cath.works and follow @CathWorks on LinkedIn. 

1. ALL-RISE: Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment is a multi-center global prospective randomized controlled trial (RCT) aimed at transforming the diagnosis and treatment of coronary artery disease (CAD) by evaluating the clinical and economic benefits of the CathWorks FFRangio^® System.

Investors:
Mike Feher
mike.feher@cath.works

Media:
Sarita Monico
sarita.monico@cath.works

Investment will accelerate AI innovation, expand financial services suite, strengthen existing offerings, and grow its ecosystem

AUSTIN, Texas, Oct. 22, 2025 /PRNewswire/ — ROLLER, the all-in-one venue management platform for leisure and attractions venues, today announced it has secured an additional US$50 million to accelerate its next-generation solutions for its customers. The round was led by existing investor Insight Partners, who also led the company’s US$50 million round in November 2023, with participation from J.P. Morgan, joining as a new funding provider.

With this investment, ROLLER will advance its mission to bring more joy to the world by helping venue operators grow faster, streamline operations, and deliver exceptional guest experiences. Building on its fast-paced product development which delivered over 100 enhancements in the last year, ROLLER will invest in AI-powered functionality that boosts efficiency, expands its financial services offerings to give customers more ways to grow, develop new product capabilities that enhance its offerings, and grow its partner ecosystem to give customers more choice and flexibility.

“Delivering value for our customers is what drives us to improve every day. This funding allows us to accelerate innovation and support so we can ultimately serve them even better,” said Luke Finn, Co-founder & CEO of ROLLER. “We want to empower attractions and leisure operators globally with the tools they need to grow, delight their guests, and thrive in an increasingly competitive environment.”

Customers will also benefit from enhanced global support, as ROLLER builds on its 24/7/365 support, where over 95% of support calls are answered in less than a minute. Recent enhancements include premium support, expanded chat, and a new hardware lab for troubleshooting issues faster.

“We are thrilled to double down on our partnership with ROLLER,” said Rachel Geller, Managing Director at Insight Partners. “Since our initial investment, we’ve continued to be impressed with the company’s growth and Luke’s and Mark’s leadership. This new round will allow ROLLER to continue driving global expansion and innovation in their category-leading platform for the leisure and attractions sector.”

Peter Bairaktaridis, Head of Innovation Economy Coverage for Australia & New Zealand at J.P. Morgan, said: “We are proud to support ROLLER as it continues to scale globally and deliver innovative solutions for the attractions and leisure industry. J.P. Morgan is committed to supporting high-growth technology companies around the world, and we’re excited to join ROLLER’s journey as they expand their reach and impact on a global stage.”

Mark Finn, Co-founder & CFO of ROLLER, added: “We are delighted to continue to invest in the success of our customers. This capital provides the flexibility to continue investing in both organic and inorganic growth opportunities, ensuring we deliver even greater advancements and value to operators around the world.”

With over 3,000+ customers across 30+ countries, ROLLER has established itself as the trusted partner for leisure and attractions businesses worldwide. Its suite of solutions empowers operators to deliver exceptional experiences and include ticketing, point-of-sale, integrated payments, memberships, gift cards, kiosks and guest experience tools. By staying relentlessly focused on creating customer value, ROLLER has grown to over 300 employees worldwide with offices in Melbourne, Sydney, San Francisco, Austin, London, Costa Rica, and Bosnia.

About ROLLER

ROLLER is the cloud-based venue management platform for modern attractions, purpose-built to remove friction from every guest touchpoint. The all-in-one solution simplifies business processes, improves efficiency, and maximizes revenue. ROLLER’s comprehensive platform includes ticketing, point-of-sale, integrated payments, memberships, gift cards, kiosks, guest experience tools, and more. To learn more, visit roller.software.

About Insight Partners

Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of June 30, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 875 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

About J.P. Morgan’s Commercial & Investment Bank

J.P. Morgan’s Commercial & Investment Bank is a global leader in banking, payments, markets and securities services. Start-ups, companies, governments and institutions entrust us with their business in more than 100 countries worldwide. With $38 trillion of assets under custody and $1.09 trillion in deposits, the Commercial & Investment Bank provides strategic advice, raises capital, manages risk, offers payment solutions, safeguards assets and extends liquidity in global markets. Further information about J.P. Morgan is available at www.jpmorgan.com.

Logo – https://laotiantimes.com/wp-content/uploads/2025/10/roller_logo.jpg